European Journal of Nuclear Medicine and Molecular Imaging 2002: Vol 29 Table of Contents

17 Pages·2002·5.1 MB·English

European Journal of
Nuclear Medicine
and Molecular Imaging
Founded in 1975
Official Journal of the European Association of Nuclear Medicine (EANM) Editor-in-Chief: H. Hundeshagen Vol. 1-15
(1976-1989); up from Vol. 16 (1990) P.J. Ell
Contents of Volume 29 - 2002
Abdel-Dayem HM — Santiago JFY Asaka M — Kato T marrow ablation in multiple myeloma and
Abletshauser C + Momose M Ascanelli S > Feggi L other haematological malignancies 1470
Acar K > Yagci M Ascoop CAPL — Groutars RGEJ Bartusek G — Dittmann H
Acton PD, Choi S-R, Pléss] K, Kung HF Asola MR, Virtanen KA, Peltoniemi P, Basilion JP — Hégemann D
Quantification of dopamine transporters Nagren K, Yu M, Mattila K, Jyrkkié S, Basoglu T, Yapici O, Aksakal E, Sahin M,
in the mouse brain using ultra-high Metsidrinne K, Nuutila P, Knuuti J Canbaz F, Albayrak S, Yesildag O
resolution single-photon emission Amino acid uptake in the skeletal Effect of O,-enriched breathing on
tomography 69] muscle measured using myocardial uptake of 9?™Tc-sestamibi
Acton PD, Hou C, Kung M-P, Plossl K, |''C}]methylaminoisobutyrate (MEAIB) 1496
Keeney CL, Kung HF: Occupancy and PET 1485 Batalla A — Chajari M’H
of dopamine D, receptors in the Audenaert K — Otte A Baudin E > Klain M
mouse brain measured using Aurengo A — Hindié E Bauer R — Puille M
ultra-high-resolution single-photon Avezaat C — Nanda D Baumgart! H-J — Scheidhauer K
emission tomography and [!*31]IBF 1507 Bax JJ, Fath-Ordoubadi F, Boersma E,
Acton PD, Kung M-P, Hou C, Plossl K, Bacher K, Brans B, Monsieurs M, Wijns W, Camici PG: Accuracy of PET
Keeney C, Kung HF: Ultra-high De Winter F, Dierckx RA, Thierens H in predicting functional recovery
resolution single photon emission Thyroid uptake and radiation dose after revascularisation in patients with
tomography imaging of the mouse after '>'I-lipiodol treatment: is thyroid chronic ischaemic dysfunction
striatum 446 blocking by potassium iodide head-to-head comparison between
Adam L-E — Hickeson M necessary? 131] blood flow, glucose utilisation and
Aguirre Costa P — Barros A Bacher K — Monsieurs M water-perfusable tissue fraction 721
Ahlstr6m KR — Elgh E Bacin F > Moins N Bax JJ, Visser FC, Poldermans D, Lingen A
Ahn B-C — Sohn S-K Bai J > Kinuya S van, Elhendy A, Boersma E, Visser CA
Aksakal E — Basoglu T Baker CSR — Chareonthaitawee P Feasibility, safety and image quality
Alan N — Kabasakal | Bakker W > Nanda D of cardiac FDG studies during
Alavi A > Hickeson M Baldwin RM — Fujita M hyperinsulinaemic-euglycaemic
Alavi A > Zhuang H Ballard C — Colloby SJ clamping 452
Albayrak S — Basoglu T Ballinger JR — Cousins C Bax JJ — Knuuti J
Alberer D > Kresnik E Balm AJM — Hoebers FJP Bayle M — Moins N
Albers FWJ — Boer JR de Bangsgaard R — Kofoed KF Becherer A — Karanikas G
Alenius S —> Bettinardi \ Bank J — Garai | Becker GA — Piert M
Alfano B — Varrone A Banner NR — Chareonthaitawee P Becker I — Rau FC
Allison R — Bartlett ML Bansal SS — Sutcliffe-Goulden JL Becker K — Wieder H
Aloj L — Del Vecchio S Barber RW — Cousins C Becker W, Schicha H: The thyroid $401
Altenvoerde G — Gratz S Bardet S — Chajari M’H Becker W — Gratz S
Altenvoerde G — Meller J Bares R > Dittmann H Becker W —> Meller J
Altland K — Puille M Bares R — Eschmann SM Beekman FJ, McElroy DP, Berger F,
Altmann A — Haberkorn U Barros A, Aparecida Cardoso M, Sheng PY, Gambhir SS, Hoffman EJ, Cherry SR
Anagnostopoulos C — Kapur A Aguirre Costa P, Pelizon C: Towards in vivo nuclear microscopy
Anjos AC — Santos A Radioguided localisation of non-palpable iodine-125 imaging in mice using
Antoch G — Freudenberg LS breast lesions and simultaneous sentinel micro-pinholes 933
Aparecida Cardoso M — Barros A lymph node mapping 1561 Beekman FJ — Jong HWAM de
Appel M — Pieterman R Bartalena L, Marcocci C, Tanda ML, Begg AC — Hoebers FJP
Appelboom T — Dumarey N Pinchera A: Management of thyroid eye Beggs AD, Hain SF, Curran KM,
Arendrup H — Kofoed KF disease S458 O'Doherty MJ: FDG-PET as
Arndt J-W — Soerdjbalie-Maikoe V Bartlett ML, Webb M, Durrant S, Morton AJ, a “metabolic biopsy” tool in non-lung
Arulampalam TH — Visvikis D Allison R, Macfarlane DJ: Dosimetry lesions with indeterminate biopsy 542
Asada T > Matsuda H and toxicity of Quadramet for bone Béhé M — Gotthardt M
Blanksma PK — Jong RM de Brauckhoff M — Gimm O
Blocklet D — Dumarey N Braun M — Hutton BI
Blomquist E — Ribom D Bree R de — Regelink G
Blomquist L —G rybiick P Brenot-Rossi | » Pasquier J
Bockisch A — Freudenberg LS Brink I — Nitzsche El
2> OUI1S; » Zambo K Brink | — Reinhardt MJ
Boer JR de, Laan BFAM van der, Pruim J Brix G, Nobke D, Glatting G, Minkov V,
Que TH, Burlage F, Krikke A Reske SN: A survey of PET activity in
Willemsen ATM, Tiebosch ATMG Germany during 1999 109] .
Albers FWJ, Vaalburg W: Carbon-11 B oOuwWwe! | » Regelink G
tyrosine PET for visualizatioannd Bruckner JD — Eary JI
protein synthesis rate assessment of BruiKn d e >B ooij J
laryngeal and hypopharyngeal Brunkhorst T, Boerner AR, Bergh S, Otto D,
carcinomas 1182 Gratz FW, Knapp WH: Pretherapeutic
BoermanO C — LavermanP assessment of tumour metabolism using
Boerner AR, Petrich T, Weckesser I a dual tracer PET technique 1416
Fricke H, Hofmann M, Otto D Bruno I — Calcagni MI
Weckesser M, Langen KJ, Knapp WH Buchegger F —D upertuisY M
Monitoring isotretinoin therapy i Buck A, Schirrmeister H, Kiihn T, Shen C,
hyroid cancer using '*F-FDG PET 23 Kalker T, Kotzerke J, Dankerl A
3oerner AR — Brunkhorst T ng G, Reske S, Mattfeldt T:F DG
soersma | > Bax JJ n breast cancer: correlation
ok B — Hindié | logical and clinical prognostic
solster AA — Hilditch TI irametet! 1317
omanji J Kapur A Buc K \ —B urger ¢
er M — Schirrmeister H Buck \4 — GoerresG W
nafous J — Moins N Buck A — Hany TI
ser RS — Chareonthaitawee P Buck A — Kaim AH
1, Bruin K de, Habraken JBA, Voorn P Buck A — Kamel I
aging of dopamine transporters in rats 3uck A — Weber B
ing high-resolution pinhole Buck AK — Schirrmeister H
gle-photon emission tomograp! Budach W — Fschmann SM
orbath I, Grégoire V, Bergstr6m M Buell U — Meyer PT
a D, Langstrém B, Pauwels S Bunjes D — Schirrmeister H
of 5 Br|bromo-2’-fluoro-2 Bunko H — Kinuya S$
uridine as a ligand for tumou! Burger C, Goerres G, Schoenes S, Buck A,
feration: validation in an animal Lonn AHR, Schulthess GK von: PET
tumour model 19 ittenuation coefficients from CT
rmans G » De Potter T images: experimental evaluation of the
rner AR — Petrich 1 transformation of CT into PET 511-ke\
ossuyt A —V anhove ( attenuation coefficients 922
G — Del Vecchio S Burger C —G oerresG W
zkurt A — Fujita M Burger C > Kamel I
randalise S — Santos A Burger (¢ >» Weber B
Brandau W — Freudenberg LS Burlage I » Boer JR de
Brans B, Lambert B, De Beule Bybel B — Leslie WD
De Winter F, Van Belle S,
Van Vlierberghe H, Hemptinne B de Cakir E — Yiiksel M
Dierckx RA: Quality of life assessment Calcagni ML, Giordano A, Bruno I,
Bijste in radionuclide therapy: a feasibility Parbonetti G, Di Giuda D, De Rossi G,
Bi study of the EORTC QLQ-C30 Troncone L, ColicchioG : Ictal brain
Binns questionnaire in palliative '>'I-lipiodol SPET during seizures pharmacologically
B therapy 1374 provoked with pentylenetetrazol: a new
Biro P — Webe Brans B, Van Laere K, Gemmel F, diagnostic procedure in drug-resistant
Bischof Delaloy rogress in th Defreyne L, Vanlangenhove P, Troisi R, epileptic patients 1298
hagnos ind treatmofe dnisetas e Dy Van V lierberg re H, Colle I aldwell CB — Callen DJA
nuclear medicine and molecular Hemptinne B de, Dierckx RA ‘allen DJA, Black SE, Caldwell CB
imaging. Highlights of the European Combining iodine-131 Lipiodol therapy Limbic system perfusion in Alzheimer’s
Association of Nuclear Medicine with low-dose cisplatin as disease measured by MRI-coregistered
Congress, Naples 2001 139 a radiosensitiser: preliminary results in HMPAO SPET 899
Bischof Delaloye A ~ Dupertuis YM hepatocellular carcinoma 928 amargo EI > Santos A
Biver F — Sanabria-Bohérquez SM Brans B — Bacher K amici PG > Bax JJ
Black SE — Callen DJA Brans B — Monsieurs M ‘amici PG » Chareonthaitawee P
‘anbaz I > Basoglu T dementia with Lewy bodies and Dearling JLJ — Southworth R
‘araco C >» Del Vecchio S Alzheimer’s disease using statistical Debatin JF — Freudenberg LS
‘araco C > Varrone A parametric mapping 615 Debus J » Henze M
arstensen S ? Kofoed KI ‘omans EFI > Regelink G Debus J > Kissel M
asara D > Rubello D onrad El > Eary Jk Deconinck I + Vanhove C
‘ermik TI > Yiiksel M ‘ordopatis P > Maina T Decristoforo C — Gabriel M
‘hacko TK > Zhuang H ‘orstens FHM: In memoriam: Wolfgang Dede F > Santiago JFY
hajari M’°H, Lacroix J, Peny A-M, Becker 837 Defreyne L — Brans B
Chesnay E, Batalla A, Henry-Amar M orstens FHM Lines from the I ANM Defrise M > Vanhove C
Delcambre C, Génot J-Y, Fruchard C, President and the Congress President Dehghani B — Zamb6 K
Bardet S: Gallium-67 scintigraphy in 1269 Del Vecchio S, Zannetti A, Ciarmiello A,
lymphoma: is there a benefit of image ‘orstens FHM — Laverman P Aloj L, CaracoC , Fonti R, Botti G,
fusion with computed tomography? 380 ‘orstens FHM — Manders JMB D’ Aiuto G, Salvatore M: Dynamic
handhury KR — Eary JI ertsen A > Kjazr A coupling of ” Tc-MIBI efflux and
‘hao T-H > Lin W-Y ‘osta DC: Dopamine neurotransmission, apoptotic pathway activation in
hareonthaitawee P, Schaefers K, Baker CSR, Parkinson’s disease and SPET 163 untreated breast cancer patients 809
lurkheimer F, Stegger L, Banner NR, ‘osta DC — Kapur A Delange F: Iodine deficiency in Europe
Yacoub M, Bonser RS, lozzo P, Camici ‘osta DC — Visvikis D and its consequences: an update
PG, Rimoldi O Assessment of infarct ‘ousins C, Skehan SJ, Rolph SM, S 404
size by positron emission tomography Flaxman ME, Ballinger JR, Bird NJ, Delcambre C > Chajari M’H
and ['SF]2-fluoro-2-deoxy-D-glucose: a Barber RW, Peters AM: Comparative Dempsey MI + Hilditch TI
new absolute threshold technique 203 microvascular exchange kinetics Detry R > Lonneux M
‘hatziioannou A > Berger | of | Br|bromide and ” Tc-DTPAi n Devous MD Sr: Functional brain imaging
‘hatziioannou Af Molecular imaging humans 655 in the dementias: role in early detection,
of small animals with dedicated PET ox P — Nanda D differential diagnosis, and longitudinal
tomographs 98 selényi Z — Gulyas B studies 1685
( ‘haudhuri TR > Zinn KR urran KM — Beggs AD Dhawan RT > Kapur A
( ‘heon GJ ? I ee DS ‘zernin J + Yap CS Di Giuda D > Calcagni MI
(Cc herry SR > Beekman FJ Dierckx R >» De Man S
hesnay I > Chajari M’H Damhaut P » Sanabria-Bohorquez SM Dierckx R » Goethals |
( hida M > Kagaya Y Dankerl A > Buck A Dierckx R >» Monsieurs M
( hiotellis f > Maina T Dannals RF — Villemagne PSR Dierckx RA > Bacher K
( ‘hoi CW > Lee JD DaSilva JN, Lourenco CM, Meyer JH, Dierckx RA > Brans B
( ‘hoi JY, Moon DH, Lee CW Shin JW, Hussey D, Potter WZ, Houle S: Imaging Dierckx RA > De Winter O
Park S-W, Hong M-K, Song J-K, cAMP-specific phosphodiesterase-4 Dierckx RA > Otte A
Park S-J, Lee HK: Prediction of left in human brain with R-[''C]rolipram Dierckx RA > Van de Wiele ¢
ventricular dilatation with thallium-201 and positron emission tomography Dierckx RA > Van Den Bossche B
SPET imaging after primary angioplasty 1680 Dietlein M — Moka D
in patients with acute myocardial iesG > Kapur A Dietlein M — Schmidt M
infarction 728 Barsy (¢ > Belhocine T Dietz A — Henze M
hoi S-R — Acton PD Beule E — Brans B Dittmann H, Dohmen BM, Kehlbach R
‘hopra MK ~ Bhatnagar A Geeter F — Vanhove C Bartusek G, Pritzkow M, Sarbia M
‘hossat F >» Moins N Man S, Gemmel P, Vlerick P, Van Rijk P. Bares R: Early changes in ['SF]FLI
‘hua| > Lees W Dierckx R: Patient’s and personnel’s uptake after chemotherapy
‘hun K-A > Sohn S-K perceptions of service quality and an experimental study 1462
‘hung J-K, Kim YK, Kim §S, Lee YJ, patient satisfaction in nuclear medicine Djian J > Nuyts J
Paek S, Yeo JS, Jeong JM, Lee DS, 1109 Doganay L — Yiiksel M
Jung HW, Lee MC: Usefulness e Potter T, Flamen P, Van Cutsem E, Dogan D = Erselcan T
of ''C-methionine PET in the evaluation Penninckx F, Filez L, Bormans G, Dohmen BM — Dittmann H
of brain lesions that are hypo- o1 Maes A, Mortelmans L: Whole-body Dohmen BM — Eschmann SM
isometabolic on SF-FDG PET 176 PET with FDG for the diagnosis Déhner H — Schirrmeister H
‘hung J-K > Lee DS of recurrent gastric cancer 525 Dérner J > Gratz S
‘iarmiello A — Del Vecchio S Rossi G — Calcagni ML Doze P, Elsinga PH, Waarde A van,
‘ingi E > Yagci M >» Sutter J — De Winter O Pieterman RM, Pruim J, Vaalburg W,
‘olas-Linhart N > Hindié F > Tribolet N — Dupertuis YM Willemsen ATM: Quantification
‘olicchio G > Calcagni MI > Winter F — Bacher K of B-adrenoceptor density in the human
‘olle | > Brans B > Winter F — Brans B heart with (S)-[''C}]CGP 12388 and
‘ollins J, Gough S: Autoimmunity in thyro > Winter O, De Sutter J, Dierckx RA a tracer kinetic model 295
id disease S 417 Clinical relevance of left ventricular Drager E — Maza S&S
‘olloby SJ, Fenwick JD, Williams ED, volume assessment by gated myocardial Dralle H — Gimm O
Paling SM, Lobotesis K, Ballard C, SPET in patients with coronary artery Drews A — Heimbold |
McKeith I, O’Brien JT: A comparison disease 957 Driesse M — Nanda D
of ™Tc-HMPAO SPET changes in De Winter O — Van de Wiele C D’ Aiuto G > Del Vecchio S
Vi
D' Inca MM 3 N Eschi nann SM, Friedel G, Paulsen F, Fukuchi M > Kagaya Y
Dr Al » Hattor N B udach W, Harer-Mouline C, Furuyama H >Iw ado Y
Duchateau CSJ HDP D ohmen BM, Bares R: FDG PET for Futatsubashi M > Torizuka I
ging of advanced non-small cell
ing cancer prior to neoadjuvant Gabriel M Decristoforo( ¢ Moncayo R
lio-chemotherapy 804 Somatostatin receptor scintigraphy
I cl mani SM, ReischiG , Bilger K Tc-EDDA/HY NIC-TOC in
Kupte
[ rschlager ] Thelen MH Graves’ disease 126
nen BM Besenfelder H, Bares R Galle P > Hindié I
uation of ak simetry of radioiodine GallowitschH J —K resnik I
benign and malignant thyroid Galuska I > Gara |
.
eans of 1odine- 124 and Gambhir SS Ell PJ Welcome to the
European Journal »f Nuclear Medicine
> Santos A ind Molec ular Imaging
> Reinhardt MJ Gambhir SS » Beekman FJ
(sal nbhir he Pe) » Berger |
Garai |, Varga J, Szomjak |
Bank J. Ficzere A. Olvaszt
Galuska | Quantitative a
Tc-HMPAO i
Garino JP —Z huang
Garlick PB — Southwe
Gasser J — Kresnik I
» Pas
> Won
>» Bran
>D
lemann G
sins ¢ obulin in
thworth R recurrent
> Takala TO
> Visvikis D irehpapagh > Hany
>» Vanhove( t J-F — Lonneux M
> Berger| M¢ > Bettinardi \V
: > Kofoed KI QO, Brauckhoff M, Thant PN
¢ P —S chumacher T Sekulla ( Dralle H: An u pdate
HMPAO lenberg LS, Antoch G, Gérges R id surgery S 447
t EJ. Beyer T. Brandau W > Calcagni MI
sch A, Debatin JI 1-PET/CT > Brix G
follicular thyroid carcinoma >» Buck A
> Seitz |
» Lokkegaard A > Sanchez-Crespo A
» Boerner AR Goerres G — Burger ¢
> Eschmann SM GoerresGW , Hany TF, Kamel I
lrichf » Kissel M SchulthessGK von, Buck A: Head and
tsch H-W » Gotthardt M eck ima ging with PET and PET/CT
tjJJ- V illemagne PSR artefacts from dental metallic implants
<9
ucnar©e 1C — Chajari M’H
er BJ — ZettinigG Goerres GW, Kamel E, Heidelberg T-NH
R > Kagaya Y Schwitter MR, Burger C, Schulthess GK
ijita M, Seiby! JP, Vaupel DB von PET~ T image co-registrationi n
lfamagnan G, Early M the thorax: influence of respiration 35]
Zoghbi SS, Baldwin RM, Horti AG Goethals I, Van De Wiele C, Slosman D,
Koren AO, Mukhin AG, Khan S Dierckx R: Brain SPET perfusion in
Bozkurt A, Kimes AS, London ED early Alzheimer’s disease where to
Innis RB: Whole-body biodistribution look? 975
radiation absorbed dose, and brain Goethals I > Otte A
SPET imaging with ['**1]5-I-A-85380 in Goethals | > Van Den Bossche B
healthy human subjects 183 Goéke B > Gotthardt M
Vil
Goldman S — Sanabria-Bohérquez SM Halldin C — Langer O comparison of 3-[!**]]iodo-a@-methyl-1
Gomez I — Kresnik | Hallett WA —G orenberg M thyrosine and °°™Tc-MIBI SPET 1455
Gorenberg M, Hallett WA, O’ Doherty MJ Hamada S — Kurihara H Herfarth KK — Henze M
Does diabetes affect ['*F]FDG Hamdy NAT — Soerdjbalie-Maikoe V Herz M > Rau FC
standardised uptake values in lung Han BH — Lee JD Hesse B > Kjaer A
cancer? 1324 Hanselmayer G — Zettinig G Hesse B > Kofoed KI
Gorges R — Freudenberg LS Hany TF, Gharehpapagh E, Kamel EM Hickeson M, Yun M, Matthies A, Zhuang H,
Gorges R — Simon D Buck A, Himms-Hagen J Adam L-E, Lacorte L, Alavi A: | se ol a
Gotthardt M, Fischer M, Naeher I, Holz JB Schulthess GK von: Brown adipose corrected standardized uptake value
Jungclas H, Fritsch H-W, Béhé M tissue: a factor to consider in based on the lesion size on CT permits
Goke B, Joseph K, Behr TM: Use of the symmetrical tracer uptake in the neck accurate characterization of lung
incretin hormone glucagon-like peptide-| and upper chest region 1393 nodules on FDG-PET 1639
(GLP-1) for the detection of insulinomas Hany TF — Goerres GW Hickeson M > Zhuang H
nitial experimental results 597 Hany TF —> Kamel I Hicks RJ > Kalff \
sottschalk J — Kaim AH Harer-Mouline C — Eschmann SM Hicks RJ — Keith CJ
ough S > Collins J Hart IR > Sutcliffe-Goulden Jl Hilditch TE, Dempsey MF, Bolster AA
irabbe E > Gratz S Hartmann T — Zamb6 K McMenemin RM, Reed NS
irahek D — Montravers I Hasart O — Ivancevic \ Self-stunning in thyroid ablation
iratz FW — Brunkhorst T Hashimoto K — Takano A evidence from comparative studic
iratz S, Dorner J. Fischer U, Behr TM Hassan-Sebbag N — Pasquier of diagnostic land '-“1 783
Béhée M, AltenvoerdeG , Meller J Hasseldam H — Kjer A Himms-Hagen J — Hany TI
Grabbe E, Becker W: 'SF-FDG hybrid Hatada K —> Kurihara H Hindié E, Leenhardt L. Vitaux |
PET in patients with suspected Hatano K — Nakahara T Colas-Linhart N, Grosclaude P. Gall
spondylitis 516 Hatherly R — Pagani M Aurengo A, Bok B: Non-medical
iratzi1 O —S chumacher T Hattori N. Schnell O, Bengel FM, Rihl J expotos raudioriodeine s and thy
reer B >K alff \V Nekolla SG, Drzezga AE, Stand! cancer S4
irégoire V — Borbath | Schwaiger M: Deferoxamine improves rat Takamiya M, Kinoshita N
Griffiths MR — Keith CJ coronary vascular responses to Yamada H, Shima T, Miyazaki H
iriffiths P — Siraj QH ympathetic stimulation in patients wit! Kouno Y, Sawada N, Sakamoto K
iroen H — Pieterman R ype | diabetes mellitus 89] Sugihara H: Interpretation of re
Onroos T — Takala TO austermans KMG — Hoebers FJP redistribution of Tc-tetrofo
irosclaude P —H indié fautmannR E — Kotzerke J In patients with acute myocai
roth P —S imon D avenga M > Nanda D infarction 1594
outars RGEJ, Verzijlbergen JI iznedar R — Yagci M Hisada K — Matsunari I
Zwinderman AH, Tiel-van But benstreit A — Kresnik I Ho S-T — Kao A
oop CAPL, HemelN M iba SI >S antiagJoF Y Hoebers FJP. Janssen HLK, Olmos RAV
1 der: Increment idelberg T-NH — GoerresG W Sprong D, Nunn AD, Balm AJM
valueo f myocardial SPET imbold I, Drews A, Syhre R Hoetnagel CA, Begg AC, Hauste
sotope rest ll/stress Kretschmar M, Pietzsch H-J KMG: Phase | study to identify
[c-tetrofosmin 46 Johannsen B: A novel technetium-99m 1YpOXia In patients with head
iriinwald F —S imon D radiolifgoar nthde 5-HT, , receptor cancer using technetium-99m
iryback P. Jacobsson H. Blomquist I derived from desmethyv!l-WAY- 100636 59.2? 1206
Schnell PO, Hellstr6m PM itigraphy DWAY 2 Hoefnagel CA — Hoebers FJP
he small intestine: a simpl Istr6m PM — Grybiick P Hoefnagel CA — Tanis PJ
urd for studofy transit witl Imeke H-J —>P etrich T Hoegerle S —N itzscheE l
ce to normal value *mel NM van — Groutars RGEJ HoekstraO S — Regelink G
wend JE — Kotzerke J mptinne B de > Brans B Hofer S —S chumacher T
jugger M — Reubi J¢ nnemann G — Geus-Oei L-F de Hoffman EJ — Beekman FJ
julyas B, Halldin C, Sé6vag6 J. Sand ennipman FA — Statius Muller MG Hofmann A, Zettinig G, Wachter S
Cselényi Z, Vas . Kiss B, Karpati | nry-Amar M — Chajari M’H Kurtaran A, Kainberger F, Dudez
Farde L: Drug distribution in man nze M, Mohammed A, Mier W. Rudat \ Imaging of aortic prosthesis
positron emission tomography stud Dietz A, Nollert J, Eisenhut M, with a combined SPET/CT d
after oral administration of the labelled Haberkorn U: Pretreatment evaluation Hofmann A — ZettinigG
neuroprotective drug vinpocetine of carcinomas of the hypopharynx and Hofmann M — Boerner AR
larynx with 'SF-fluorodeoxyglucose Hofmann M — Petrich 17
Haberkorn U, Altmann A, Eisenhut M l-o-methyl-L-tyrosine and Hégemann D, Basilion JP: “Seeing inside
Functional genoanmd iprocteosmic s Tc-hexakis-2-methoxyisobutylisonitrile the body”: MR imagingof vyene
the role of nuclear medicine 115 324 expression 400
Haberkorn U — Henze M lenze M, Mohammed A, Schlemmer H, Hogg A — Kalff \
Haberkorn U — Mier W Hertarth KK, Mier W, Eisenhut M, Holm S > Kofoed KI
Habraken JBA — Booij J Debus J. Haberkorn U: Detection Holz JB —G otthardt M
Hain SF > Beggs AD of tumour progression in the follow-up Hong M-K — Choi JY
Halldin C — Gulyas B of irradiated low-grade astrocytomas Horenblas S > Tanis PJ
Vill
Hori M — Takasawa M Jiang G-L — Zeng Z-C correction in a combined PET/CT
Horti AG — Fujita M Joe A > Reinhardt MJ system: evaluation of the effect of
Hoskin PJ: FDG PET in the management of Joe AY — Reinhardt MJ lowering the CT tube current 346
lymphoma i clinical perspective 449 Johannsen B, Pietzsch H-J: Development of Kamel E —G oerresG W
Hosoi R > Ishikawa M technetium-99m-based CNS receptor Kamel EM — Hany TI
Hou ¢ Acton PD ligands: have there been any advances? Kanayama S — Matsunari I
Houle S » DaSilva JN 263 Kanetaka H — Matsuda H
Hove JD — Kofoed KI Johannsen B — Heimbold | Kang E > Lee DS
Host | » KofoedK I Jong HWAM de, Beekman FJ, Kanno T — Torizuka 1
Hussey D —D aSilva Viergever MA, Rijk PP van Kao A, Shiau Y-C, Tsai S-C, Wang J-J
Hustinx R > Bel The Simultaneous ”™T¢ I'l dual-isotope Ho S-T: Technetium-99m met
Hutton BI M., Thurfjell L, Lau DYH SPET with Monte Carlo-based hoxyisobutylisonitrile imaging for
Image registration: an essential tool for down-scatter correction 1063 parathyroid adenoma: relationship to
Jong LJ de, Pruim J, Elsinga PH, P-glycoprotein or multidrug resistance
Hwang S$ Jongen MMGJ, Mensink HJA related protein expression 1012
Hyde N Vaalburg W: Visualisation of bladder Kapur A, Latus KA, Davies G, Dhawan RT,
cancer using ''¢ choline PET Eastick S, Jarritt PH, Roussakis G
first clinical experience 1283 Young MC, Anagnostopoulos ¢
Jong M de > Nanda D Bomanji J, Costa DC, Pennell DJ
Jong RM de, Blanksma PK, Waarde A van Prvulovich EM, Ell PJ, Underwood SR
Veldhuisen DJ van: Measurement of 4 comparison of three radionuclide
myocardial $-adrenoceptor density myocardial perfusion tracers in clinical
in clinical studies: a role for positron practice: the ROBUST study 1608
emission tomography? 88 Karanikas G, Becherer A, Wiesner K
Jongen MMGJ — Jong LJ de Dudezak R, Kletter K: ACE inhibition
Jonsson ¢ > Pagani M is Superior to angiotensin receptor
Joseph K » Gotthardt M blockade for renography in renal artery
June HW » Chung J-K stenosis 312
Jungclas H > Gotthardt M Karlikaya C —Y iiksel M
JyrkkiéS Asola MR Karpati E —G ulyas B
Kartheuser A — Lonneux M
Kabasakal L, TurkmenC Ozmen O Kashyap R — Bhatnagar A
Alan N ( ynsel ( | slu | Is furosemide Kato T, Tsukamoto E, Kuge Y, Katoh C,
administration effective in improving Nambu T, Nobuta A, Kondo S
the accuracy of determination of Asaka M, Tamaki N: Clinical role
lifferential renal function by means f 'SF-FDG PET for initial staging
of technetium-99m DMSA in patients of patients with extrahepatic bile
with hydronephrosis 143 duct cancer 1047
Kagaya Y, Chida M, Imahort Y, Fujii R Kato T, Tsukamoto E, Kuge Y, Takei T
Namiuchi S, Takeda M, Yamane Y Shiga T, Shinohara N, Katoh C
Otani H, Watanabe J, Fukuchi M Nakada K, Tamaki N: Accumulation
Tezuka F, Ido T, Shirato K: Effect of of [''C]acetate in normal prostate and
> Tsuchida angiotensin converting enzyme inhibition benign prostatic hyperplasia
V, Perka ¢ Hasart O, Sandr xk D on myocardial phosphoinositide comparison with prostate cancer 1492
Munz DL: In izing of low-grade bone metabolism visualised with 1-[1-''C] Katoh A —> Matsuda H
nfection with a technetlum-99m butyryl-2-palmitoyl-rac-glycerol in Katoh ¢ > lwado Y
labelled m« mocional anti- NCA-90 Fab myocardial infarction in the rat 1516 Katoh C > Kato T
fragment i patients with previous joint Kaim AH, Weber B, Kurrer MO, Katoh C — Shiga 1
surgery $47, 835 WesteraG , Schweitzer A, Gottschalk J Katoh C — Yoshinaga K
Iwado Y, Yoshinaga K, Furuyama H, Ito Y SchulthessGK von, Buck A: '*F-FDG Kawai Y — Yoshinaga K
Norivasu K K iton ( Kuge y and '*F-FET uptake in experimental soft Kawamata M — Takasawa M
| | umaki N Decrease tussue infection 648 Kawashima H — Kiyono Y
epe Kainberger F — Hofmann A Keeney ( > Acton PD
Kalff V, Hicks RJ, Ware RE, Greer B. Keeney CL — Acton PD
Binns DS, Hogg A: Evaluation of Kehlbach R — Dittmann H
high-risk melanoma: comparison Keiding 5 > Weiss M
Jacobsson H » Pagani M of ['SF]FDG PET and high-dose ®’Ga Keith CJ, Miles KA, Griffiths MR,
Jacobsson H » Sanchez-Crespo A SPET 506 Wong D, Pitman AG, Hicks RJ
Jahn M — Piert M Kalker T > Buck A Solitary pulmonary nodules: accuracy
Jana S —S antiago JFY Kallajoki M > Takala TO and cost-effectiveness of sodium iodide
Janssen HLK >» Hoebers FJP Kamel E, Hany TF, Burger C, Treyer V, FDG-PET using Australian data 1016
Jarritt PH — Kapur A Lonn AHR, Schulthess GK von, Kelbek H — Kofoed KI
Jeong JM — Chung J-K Buck A: CT vs Ge attenuation Kerrou K — Montravers F
Kettner BI, Enzweiler CNH, Sandrock D, Kletter K — Karanikas G Krikke A > Boer JR de
Reisinger |, Munz DL: Electron beam Knapp WH: Nuclear medicine and Kroon BBR — Tanis PJ
computed tomography and ventilation radiology: where are they going? Kriiger A > Rau FC
perfusion scintigraphy in the diagnosis Knapp WH — Boerner AR Kubo A — Nakahara T
of pulmonary embolism 585 Knapp WH — Brunkhorst T Kuge Y — Iwado Y
Khan S — Fujita M Knapp WH — Petrich T Kuge Y > Kato T
Kikuchi K — Nakahara T Knaus E + Nanda D Kuge Y — Yoshinaga K
Kim D-H — Sohn S-K Knudsen GM > Pinborg LH Kiihn T — Buck A
Kim E-H — Lee JD Knust EJ — Freudenberg LS Kiihnlein R — Kissel M
Kim GE — Lee JD Knuuti J, Scheibert HR, Bax JJ: The need Kumnig G — Kresnik E
Kim JS, Moon DH, Lee SG, Lee YJ, for standardisation of cardiac FDG PET Kung HF — Acton PD
Park KM, Hwang S, Lee HK imaging in the evaluation of myocardial Kung M-P — Acton PD
The usefulness of hepatobiliary viability in patients with chronic Kupferschliger J - Eschmann SM
scintigraphy in the diagnosis of ischaemic left ventricular dysfunction Kurihara H, Nakamura S, Hatada K,
complications after adult-to-adult living 1257 Takehana K, Hamada S, Watanabe J
donor liver transplantation 473 Knuuti J Asola MR Yuyama R, Mimura J, Sugiura T
Kim J-G — Sohn S-K Knuuti J — Takala TO Iwasaka T: Early prediction of regional
Kim KB — Lee DS Kobayashi J — Shiga T functional recovery in reperfused
Kim KH — Lee JD Kobayashi K — Ishikawa M myocardium using single-injection
Kim S — Chung J-K Koéter G — Pieterman R resting quantitative electrocardiographic
Kim YK — Chung J-K Kofoed KF, Carstensen S, Hove JD, gated SPET 458
Kim YK — Lee DS Freiberg J, Bangsgaard R, Holm S, Kurrer MO — Kaim AH
Kimes AS —> Fujita M Rabol A, Hesse B, Arendrup H, Kurtaran A — Hofmann A
Kinoshita N — Hirata Y Kelbek H: Low whole-body insulin Kvinnsland Y, Bruland , Moe L, Skretting A
Kinuya S, Yokoyama K, Li X-F, Bai J, sensitivity in patients with ischaemic \ method for measurement of the
Watanabe N, Shuke N, Takayama 1 heart disease is associated with impaired uptake patterns of two beta-emitting
Bunko H, Michigishi T, Tonami N myocardial glucose uptake predictive of radionuclides in the same tissue section
Hypoxia-induced alteration of tracer poor outcome after revascularisation 991 with a digital silicon detector
accumulation in cultured cancer cells Kofoed KF, Hove JD, Freiberg J, Host U, application to a study of *°SrC]
and xenografts in mice: implications for Holm S, Kelbek H: Variability of and '°Sm-EDTMPin a dog with
pre therapeutic prediction of treatment insulin-stimulated myocardial glucose spontaneous Osteosarcoma 19]
oucomes with Tc-sestamibi, 2°'T] uptake in healthy elderly subjects 1600
chloride and ” Tc-HL9! 1006 Kogler D — Kresnik F aan BFAM van der > Boer JR de
Kinuya S > Li X-I Koéhrle J — Simon D aan BFAM van der > Regelink G
Kishibe Y — Yamauchi H Kohya T — Yoshinaga K abarre P > Moins N
Kiss B —G ulyas B Kondo S — Kato T acorte| » Hickeson M
Kissel M, Peschke P, Subr V, Ulbrich K, Kénig K — Markwardt J acroix J > Chajari M’H
Strunz AM, Kiihnlein R, Debus J Konishi J — Takeuchi R ambert B > Brans B
Friedrich E: Detection and cellular Koérber C > Simon D ammertsma AA > Weerdt AP van det
localisation of the synthetic soluble Koren AO —> Fujita M andman-Parker J — Montravers I
macromolecular drug carrier PHPMA Kornya L — Zambo K angen KJ — Boerner AR
1055 Koshida K — Li X-I anger O, Halldin C: PET and SPET tracers
Kitabatake A — Yoshinaga K Késter G > Meller J for mapping the cardiac nervous system
Kitagawa K — Takasawa M Kotzerke J, Volkmer BG, Neumaier B, 416
Kitapg: M — Yagci M Gschwend JE, Hautmann RE, Reske SN Langstr6m B > Borbath |
Kiyono Y, lida Y, Kawashima H, Ogawa M, Carbon-11 acetate positron emission Laniéce BRP > Zimmer |
Tamaki N, Nishimura H, Saji H tomography can detect local recurrence Larson SM >» Yeung HW
Norepinephrine transporter density of prostate cancer 1380 Larsson SA > Pagani M
as a Causative factor in alterations in Kotzerke J — Buck A Larsson SA >» Sanchez Crespo A
MIBG myocardial uptake in NIDDM Kouno Y — Hirata Y Laryea D > Borbath |
model rats 999 Koyama T — Shiga T Lass P: Nuclear medicine technologist
Kjzr A, Cortsen A, Rahbek B, Kriitschmer J — Markwardt J training in European countries 1083
Hasseldam H, Hesse B: Attenuation Krausch M —> Simon D Latus KA — Kapur A
and scatter correction in myocardial Krause TM — Reinhardt MJ Lau DYH — Hutton BE
SPET: improved diagnostic accuracy in Krenning EP — Geus-Oei L-F de Laverman P, Boerman OC, Corstens FHM,
patients Ww ith suspected coronary artery Kresnik E, Gallowitsch HJ, Mikosch P, Oyen WJG: Fluorinated amino acids for
disease 1438 Wiirtz F, Alberer D, Hebenstreit A, tumour imaging with positron emission
Klain M, Ricard M, Leboulleux S, Baudin E, Kogler D, Gasser J, Igerc 1, Kumnig G, tomography 681, 834
Schlumberger M: Radioiodine therapy Gomez I, Lind P: 'SF-FDG positron Le Bars D > Zimmer L
for papillary and follicular thyroid emission tomography in the early Leahy R — Berger F
carcinoma S 479 diagnosis of enterocolitis: preliminary Leboulleux S > Klain M
Klein LJ — Weerdt AP van der results 1389 Leder G — Seitz |
Klett R — Puille M Kretschmar M — Heimbold | Lee CW — Choi JY
id P: Strategies of radioiodine ther ipy for Eberlein-Richter P, SchmidtG
Graves’ disease S 453 Konig K: Matching the changing need
nd P — Kresnik I of thyroxin after radioiodine therapy
ndahl SGE — Sanchez-Crespo A by TSH-controlled substitution
en A van > Bax JJ \ prospective study over 8 years of 78
nke RP — Puille M female patients with toxic thyroid
1 K-D — Zeng Z~-( id; enomas or toxic nodular goiters 1704
ybotesis K > Colloby SJ Marsden PK > Sutcliffe-Goulden Jl
oening AM > Berger | Marshall JF —S utcliffe-Goulden JI
ondon ED — Fujita M Masoomi MA — Siraj QH
AHR — Burger (¢ Mastrippolito R — Zimmer
mn AHR — KamelI Mastrocolla L —V itolaJ V
x M. Reffad A-M, Detry R Mather SJ: VirRAD
Kartheuser A, Gigot J-F, Pauweis S agiopnarmacy tearm
FDG-PE] proves the staging and ur input needed 110
ft patients with recurrent i H, Kan! etaka H, Ohnishi
t ‘ Callht I Ai. ishi E, Nakano S. K
G — Maina 1 in SPET
co CM — DaSilva JN
rd A, WerdLeM,l Friibenrg |
ypact of diagnostic SPET > TakeuchiR
th a dopamine M >»M atsunari |
M ? i isdW M
Matsud aki
NekollaSG , Takekosh (
MM, Mazzi | Hisada K: Myocardial dist
Pauwels EKJ F-FDG and
On iab=de lled 7.t lucor
| peptides for
suck A
> Hickeson M
Asola MR
> Zimmer |
ncia R Ce VOrSKI | Zandet \
> Yeung HW Winter H, Sterry W. Munz DI
Mactarlan > Bartlett MI shielding of hot spots
Macl » PiertM ft cutaneous
MadelmontJ -C —M oins N mproves accuracy
Maecke HR — Schumacher scintigraphic sentine
MaedaM — Torizuka MOSLICS 1399
Maes A — De Potter 1 > Lupetti A
Maes A — Mesotten | ly VR, O'Sullivan JM
Maes A > Nuyts J lirecuions for unsealed source
Maina T, Nock B, Nikolopoulou A clide therapy for bone
iou P. Loudos G, Maintas D metastases 127]
raopalls P. Chiotellis I McElroy DP — Beekman FJ
Ic |Demotate, a new Ic McKeith I — Colloby SJ
octreotate analogue McMenemin RM — Hilditch Tt
he detection of somatostatin McNamara D > Montravers |
receptor-positive tumours Medina RA — Southworth R
synthesis and preclinical results Meijer S — Statius Muller MG
Meller J, Becker W The continuing
Maintas D > Maina 1 mportance of thyroid scintigraphy in the
Mallek D von —> Reinhardt MJ era of high-resolution ultrasound S 425
Manders JMB, Corstens FHM: Radioiodine Meller J, K6ster G. Liersch T, Siefker |
therapy of euthyroid multinodular Lehmann K, Meyer I, Schreiber K
eoitres S 466 AltenvoerdeG , Becker W: Chronic
Manka-Waluch A > Reinhardt MJ bacterial osteomyelitis: prospective
Mansberg R > Lees W comparison of 'SF-FDG imaging with
Marcocci C — Bartalena | a dual-head coincidence camera and
Markwardt J, Kratschmer J, Richter M, In-labelled autologous leucocyte
Reiche K, Sprenger H-J, scintigraphy 53
Meller J —G ratz S Monsieurs M — Bacher K Nekolla SG — Momose M
Mensink HJA > Jong IJ de Montravers F, McNamara D Nepp J — Zettinig G
Merlo A — Schumacher T Landman-Parker J, Grahek D, Neumaier B > Kotzerke J
Mesotten L, Maes A, Van de Wert | Kerrou K, Younsi N, Wioland M, Neumaier B —> Seitz |
Mortelmans L: PET Leverger G, Talbot JN: ['SF]FDG in Nev erve J > Momose M
radiopharmaceuticals used in viability childhood lymphoma: clinical utility Nibbering PH — Lupetti A
studies in acute myocardial infarction and impact on management 1155 Nieweg OE — Tanis PJ
a literature survey 3 Moon DH — Choi JY Nikolopoulou A — Maina 1
Messer P — Schirrmeister H Moon DH — Kim JS Nishimura H — Kiyono \
Mestas D — Moins N Morales B — Pruzzo R Nishimura T > Ishikawa M
Metcalfe MJ > Prvulovich| Moreau M-F — Moins N Nishimura T — Tatsumi M
Metsirinne K > Asola MR Mori H — Li X-I Nishizawa S — Tsuchida T
Meyer GJ > Petrich 7 Morin K — Nanda D Nitzsche EU, Hoegerle S, Mix M, Brink |
Meyer 1 — Meller J Mortelmans L — De Potter 1 Otte A, Moser E, Imdahl A: Non-invasi
Meyer JH — DaSilva JN Mortelmans | > Mesotten | differentiation of pancreatic le stONS: 1S
Meyer PT, Sturz L, Sabri O, Buell | Mortelmans L — Nuyts J analysis of FDG kinetics superior to
Preoperative brain mapping using |'°O] Morton AJ — Bartlett MI semiquantitative uptake value analysis
water activation PET provides evidence Moser I » Nitzsche El > 4
on altered language networks in an adult Mukhin AG — Fujita M Nobezawa S — Torizuka 1
brain tumour patient 1705 Miiller S — Schirrmeister H Nobuta A — Kato T
Michel BF — Pasquier J Miiller-Girtner HW — Simon D Nock B — Maina T
Michel O — Schmidt M Mulligan R > Visvikis D Nofzinger EA >O tte A
Michigishi T > Kinuya S Mundun A: AbstracVtosl 8, No.8 162 Noirault E — Moins N
Michigishi T > Li X-I Munz DI > Ivancevic V Nollert J — Henze M
Mier W, Haberkorn | Eisenhut M: |'SFJFLT: Munz DI > Kettner BI Noriyasu K > lwado Y
portrait of a proliferation marker 165 Munz DI > MazaS Noriyasu K — Yoshinaga K
Mier W —> Henze M Murase K > Takasawa M Nobke D — Brix G
Mikosch P — Kresnik I Mure M > Sanchez-( respo A Novak-Hofer |, Schubiger PA
Milan G > Varrone A Copper-67 as a therapeutic nuclid
Miles KA — Keith CJ Naeher | — Gotthardt M radioimmunotherapy 821
Millard R — Saunders M Nagata M > Nakahara T Nunn AD — Hoebers FJP
Mimura J > Kurihara H Nagren K — Asola MR Nuutila P — Asola MR
Minkov V >B rix G Naimi E — Nanda D Nuutila P — Takala TO
Mirzaitehrane M — Santiago JFY Nakada K — Kato 17 Nuyts J, Mortelmans L, Van de Wert I
Mix M — Nitzsche El Nakahara T, Togawa T, Nagata M, Djian J, Sambuceti G, Schwaiger M
Miyazaki H — Hirata Y Kikuchi K, Hatano K, Yui N, Kubo A Touboul P, Maes A: Cardiac phantom
Mohammed A — Henze M Detection and chemoradiotherapeutic measurement validating the
Moins N, D’Incan M, Bonafous J, Bacin I evaluation of advanced esophageal methodology for a cardiac multi-centre
Labarre P. Moreau M-F, Mestas D squamous cell carcinoma using trial with positron emission tomography
Noirault E, Chossat F, Berthommier E, gallium-67 SPET: a preliminary study 1588
Papon J, Bayle M, Souteyrand P. 1072 Nyberg | > Elgh I
Madelmont J-C, Veyre A Nakajima K > Matsunari | Nyren S > Sanchez-( respo \
I-N-(2-diethylaminoethy])-2 Nakamura I > Shiga 7
iodobenzamide: a potential imaging Nakamura S > Kurihara H Oei H-¥ > Geus-Oei L-I
agent for cutaneous melanoma Nakano S > Matsuda H Ogawa M > Kiyono ¥
staging 1478 Nambu T > Kato 7 Ohnishi 1 > Matsuda H
Moka D, Dietlein M, Schicha H Namiuchi S > Kagaya Y Oikonen V > Takala TO
Radioiodine therapy and thyrostatic Nanda D, Jong M de, Vogeis R, Okada H > Torizuka T
drugs and iodine S 486 Havenga M, Driesse M, Bakker W, Okazawa H — Yamauchi H
Moka D = Schmidt M Bijster M, Avezaat C, Cox P. Morin K, Oku N — Takasawa M
Momose M, Abletshauser C, Neverve J Naimi E, Knaus E, Wiebe L, Smitt PS Olmos RAV > Hoebers FJP
Nekolla SG, Schnell O, Standl I Imaging expression of adenoviral Oltenfreiter R — Van de Wiele C
Schwaiger M, Bengel FM HSV 1-tk suicide gene transfer using the Olvaszt6 S — Garai I
Dysregulation of coronary nucleoside analogue FIRU 939 Onsel C — Kabasakal I
microvascular reactivity in Niisman B — Elgh I O’Brien JT — Colloby SJ
asymptomatic patients with type 2 Neglia D, Sambuceti G, lozzo P, L’ Abbate A, O'Doherty MJ — Beggs AD
diabetes mellitus 1675 Strauss HW: Myocardial metabolic and O’ Doherty MJ — Gorenberg M
Moncayo R — Gabriel M receptor imaging in idiopathic dilated O'Doherty MJ — Sutcliffe-Goulden JI
Monsieurs M, Brans B, Bacher K, cardiomyopathy 1403 O'Sullivan F > Eary JI
Dierckx R, Thierens H: Patient Nekarda H > Wieder H O'Sullivan JM — McCready VR
dosimetry for ‘!1-MIBG therapy Nekolla SG — Bengel FM Osaki Y > Takasawa M
for neuroendocrine tumours based Nekolla SG — Hattori N Otani H —> Kagaya ¥
on '23]-MIBG scans 1581 Nekolla SG — Matsunari | Ott K > Wieder H
Pereira Neto CC — Vitola JV Pruzzo R, Morales B, Peiia M
Perka C — Ivanéevié \ Right intrathoracic kidney: an incidental
Permanetter B — Bengel FM finding 1553
Peschel C — Scheidhauer K Prvulovich E, Metcalfe MJ: Nuclear
Peschke P — Kissel M cardiology in the UK: activity and
Peters AM — Cousins( ¢ practice 1997 553
Petersson J — Sanchez-Crespo A Prvulovich E — HydeN
Petrich T, Borner AR, Otto D, Hofmann M Prvulovich EM — Kapur A
Knapp WH: Influence of rhTSH Puille M, Altland K, Linke RP.
yn |'SF]fluorodeoxyglucose uptake Steen-Miiller MK, Klett R, Steiner D
ittt ferentiated thyroid carcinoma Bauer R Tc-DPD scintigraphy
in transthyretin-related familial
Helmeke H-J Meyer GJ iumyloidotic polyneuropathy 376
» WH, Potter E: Establishment Pujol JF —Z immer |
active astatine and iodine uptake Pulkki K —T akalaT O
cancer cell lines expressing the
human sodium/iodide symporter 842
etrich T — Boerner AR Qin L-X — Zeng Z-(
Phelps ME — Yap CS antelli M —V arrone A
Pichard( ¢ > DupertuisYM TH — Boer JR de
Piert M, Machulla H-J, Jahn M, Stahl
lt A, Becker GA, Zittel TT » Kofoed KI
f porcine bone blood flow >»K jaer A
ism in high-turnover bon > Wong C-vO
sured Dy O}H,O ar » Santos A
1On Positron EMISSIOI Weber WA, Wester H-J, Herz M
QQ)7 Kriiger A, Schwaiger M
Willemsen A, Appel M ywitsch-Schmidtke R
Koéter G, Vaalburg W F|Fluoroethy!
Visualisation and assessmet
protein synthesis rate of lung r from inflammat
ng carbon-1|1 tyrosine odes 039
emission tomography RavertH T — Villemagne PSR
> Doze P Reed NS —>H ilditch TI
> Heimbold I \-M — Lonne
> Johannsen B ik G, Brouwer J
> Status Muller MG 1an BFAM van der, Vaa
Videbek C, Svarer ¢ Hoekstra OS, Comans EFI, Vissink A
gaard S, Paulson ¢ IB Knudsen GM Leemans CR, Roodenburg JLN
t n of 1]PE21 bindin Detection of unknown primary tumours
dopamine transporters with SPET int metastases in patients
vith cervical metastases alue
Pinchera A — Bartalena| 1! FDG-PET versus conventional
Pinheiro \ > Santos ies 1024
Piotto A > RubelloD > Markwardt J
Pirich ¢ » ZettinigG » Scheidhauer K
Pitman AG — Keith CJ gman HIE — Stokkel MPM
Plenevaux A — Zimmer | C, Schneider P: Radioiodine
LH Pléss| K — Acton PD y of thyroid autonomy S47!
M Poldermans D — Bax JJ Reiners C >S imon D
\ Ponzo F — Zhuang H Reinhardt MJ, Brink |, Joe AY, Mallek D
MPM Postiglione A — Varrone A von, Ezziddin S, Palmedo H, Krause TM
Pitter E — Petrich T Radioiodine therapy in Graves’ disease
Potter WZ — DaSilva JN based on tissue-absorbed dose
Powitan Y — Eary JI calculations: effect of pre-treatment
Preece A — Saunders M thyroid volume on clinical outcome
Pritzkow M — Dittmann H Ltia
Probst A —S chumacher T Reinhardt MJ, Joe A, Mallek D von,
Pruim J — Boer JR de Zimmerlin M, Manka-Waluch A
Pruim J —D oze P Palmedo H, Krause TM: Dose selection
Pruim J — Jong UJ de for radioiodine therapy of borderline
Pruim J — Pieterman R hyperthyroid patients with multifocal
Pruim J —R egelink G and disseminated autonomy on the basis